Bial vs Grifols, S.A.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
Market cap history
● Bial● Grifols, S.A.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | Bial | Grifols, S.A. GRF.MC · #2,597 in the world |
|---|---|---|
| Profile | ||
| Country | 🇵🇹 Portugal | 🇪🇸 Spain |
| Sector | Healthcare | Healthcare |
| Industry | — | Pharmaceutical |
| Founded | 1924 | 1940 |
| Size | ||
| Market cap | — | $7.9 B |
| Revenue | — | $8.9 B |
| Net income | — | $477 M |
| Employees | — | 26,314 |
| Valuation | ||
| P/E ratio | — | 16.5× |
| Price to sales | — | 0.9× |
| Price to book | — | 0.9× |
| Free cash flow yield | — | 11.2% |
| Profitability | ||
| Gross margin | — | 38.0% |
| Operating margin | — | 16.5% |
| Net margin | — | 5.3% |
| Return on equity | — | 5.1% |
| Growth | ||
| Revenue growth | — | 8.7% |
| Cash | ||
| Free cash flow margin | — | 10.4% |
| Altman Z-score zone | — | — |
| Data as of | Market cap — | Market cap Aug 2026; ratios FY2025 |